Conclusion: These results confirm the absence of a neurocognitive risk associated with statin treatment and suggest a potential favourable role of statins. Randomized clinical trials with an ad hoc design are needed to explore this potential neuroprotective effect.
PubMed 34871380 ↗Statins
The short answer. There isn't much data on Statins yet — 16 mentions, 10 with a clear outcome — so treat these numbers as anecdotal. It is most often used for heart & lipids: 100% of 5 reports say that improved. It is well studied — 1,814 meta-analyses on PubMed.
From 16 mentions in total — the rest didn't say how it went and aren't counted.
What Statins does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 1,814 meta-analyses on PubMed ↗ · 2,354 randomized trials ↗
Conclusion: Conclusion: This review further confirms that high-intensity statins reduce LDL by ≥50%, favoring rosuvastatin over atorvastatin. Additional data are needed to confirm the clinical significance on cardiovascular outcomes using real-world studies.
PubMed 36847307 ↗Conclusion: Ezetimibe or PCSK9 inhibitors may reduce non-fatal MI and stroke in adults at very high or high cardiovascular risk who are receiving maximally tolerated statin therapy or are statin-intolerant, but not in those with moderate and low cardiovascular risk.
PubMed 35508321 ↗Conclusion: For primary prevention of cardiovascular disease, the risk of adverse events attributable to statins was low and did not outweigh their efficacy in preventing cardiovascular disease, suggesting that the benefit-to-harm balance of statins is generally favourable. Evidence to support tailoring the type or dosage of statins to account for safety concerns before starting treatment was limited.
PubMed 34261627 ↗1,533 human trials on ClinicalTrials.gov test Statins — 857 completed, 131 recruiting now. See all on ClinicalTrials.gov ↗
- EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) · Lipid Disorder · 2023
- Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study · Statin Adverse Reaction · 2026
- A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting · Hypercholesterolemia · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
NIH has funded 109 research projects with Statins in the title, $125,887,790 in total (1999–2026). NIH RePORTER ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“my LDL cholesterol was down to 100, a 50% improvement using 5mg and slightly better eating”
“Considering that heart disease is more likely to kill you than anything else, I don't see how taking a low dose statin isn't worth it.”
“I would also suggest avoiding statins, those are big pharma marketing garbage.”
Top discussions (5)
- Analyzed 75 longevity papers. Most of your stack is a nothing-burger. Here's what actually moves mortality ↗
- My top 10 takeaways from Rhonda Patrick's new episode with Dr. Ben Bikman about insulin resistance ↗
- Unclogging Arteries: Follow up ↗
- Doc said my testosterone is too high ↗
- Suggestions for quick motivation to get moving? Need to work on lowering BP and cholesterol. ↗
Statins compared
Other options for heart & lipids
Sources
- User reports: 16 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- LiverTox (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate